文献速递介入腹部DSACTMR

早期或中期肝细胞癌经导管动脉化疗栓塞术后不完全缓解的预测模型:结合肝动脉造影与横断面影像的考量

A predictive model of incomplete response after transarterial chemoembolization for early or intermediate stage of hepatocellular carcinoma: consideration of hepatic angiographic and cross-sectional imaging.
PubMed 文献 · Abdom Radiol (NY) · 2020-08-06

本研究回顾性纳入60例肝细胞癌患者共139个靶病灶,基于肝动脉造影和横断面影像特征建立cTACE术后不完全缓解的预测模型;肿瘤大小>50 mm、中央位置及非致密肿瘤染色为不完全缓解的预测因素,决策树分类准确率为78.4%。

要点

  • 肿瘤大小>50 mm、中央位置、非致密肿瘤染色是cTACE术后不完全缓解的预测因素。
  • 决策树模型对治疗反应的分类准确率为78.4%。
  • 行cTACE时应将这些因素纳入考虑。

核心结论

  • 肿瘤大小>50 mm、肿瘤位于中央位置及非致密肿瘤染色是cTACE术后不完全缓解的预测因素。
  • 行cTACE时应将这些因素纳入考虑。

研究设计与样本

  • 回顾性研究纳入2013年2月至2019年3月接受cTACE的60例肝细胞癌患者共139个靶病灶。
  • 评估的肝动脉造影特征包括供血动脉数目、肿瘤血管性、造影肿瘤染色、血管湖现象及肝动脉-门静脉分流。
  • 评估的横断面影像特征包括肿瘤范围、位置、大小及强化方式。
  • 治疗反应采用mRECIST标准评估。
  • 采用逻辑回归分析确定治疗反应的潜在预测因素,并以分类与回归树(CART)计算决策树。

关键影像表现/征象

  • 肝动脉造影可观察供血动脉数目、肿瘤血管性、肿瘤染色、血管湖现象及肝动脉-门静脉分流。
  • 横断面影像可观察肿瘤范围、位置、大小及强化方式。

诊断标准与关键数值

  • 肿瘤大小>50 mm预测不完全缓解:P=0.005,比值比7.25,95%CI 1.79-29.33。
  • 中央位置预测不完全缓解:P=0.007,比值比0.14,95%CI 0.03-0.59。
  • 非致密肿瘤染色预测不完全缓解:P<0.001,比值比0.08,95%CI 0.02-0.28。
  • 决策树分类治疗反应的准确率为78.4%。
  • 治疗反应采用mRECIST标准评估。

临床应用与阅片要点

  • 行cTACE时应将肿瘤大小>50 mm、中央位置及非致密肿瘤染色纳入考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of the present study is to develop a predictive model for incomplete response (IR) after conventional transarterial chemoembolization (cTACE) for hepatocellular carcinoma (HCC) based on hepatic angiographic and cross-sectional imaging.

METHODS: Sixty patients with 139 target HCC lesions who underwent cTACE from February 2013 to March 2019 were included in this retrospective study. Hepatic angiographic features were identified: the number of feeding arteries, vascularity of the tumor, tumor staining on angiography, vascular lake phenomenon, and hepatic arterio-portal shunt. Cross-sectional imaging features were also identified: tumor extent, location, size, and enhancement pattern. Treatment response was assessed by the modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria. Logistic regression analysis was performed to determine the potential predictive factors for treatment response. To validate the predictive value of potential factors, the means of a decision tree were also calculated by Classification and Regression Tree (CART). P < 0.05 was considered statistically significant.

RESULTS: The IR rate was 43.2% (60/139) in the entire study population. Logistic regression analysis showed that a tumor size > 50 mm (P = 0.005; odds ratio, 7.25; 95% CI 1.79-29.33), central location (P = 0.007; odds ratio, 0.14; 95% CI 0.03-0.59), and nondense tumor staining (P < 0.001; odds ratio, 0.08; 95% CI 0.02-0.28) were predictors of IR after cTACE. Decision tree analysis showed a good ability to classify treatment response with an accuracy of 78.4%.

CONCLUSION: Tumor size > 50 mm, central tumor location, and nondense tumor staining were predictors of IR after cTACE. These factors should be taken into consideration when performing cTACE.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Tao PY, Zhang ZS, Wang TC, et al. A predictive model of incomplete response after transarterial chemoembolization for early or intermediate stage of hepatocellular carcinoma: consideration of hepatic angiographic and cross-sectional imaging. Abdom Radiol (NY). 2020. PMID: 32761406. doi:10.1007/s00261-020-02701-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。